CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.12
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
CureVac Market Cap
CureVac has a market cap or net worth of $1.15 billion as of December 5, 2025. Its market cap has increased by 105.59% in one year.
Market Cap
1.15B
Enterprise Value
705.88M
1-Year Change
105.59%
Ranking
Category
Stock Price
$5.12
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.15B, a decrease of -88.28%. That is a compound annual growth rate of -33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.15B | 50.73% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |